Skip to main content
Rashi Peripherals Limited logo

Rashi Peripherals Limited — Investor Relations & Filings

Ticker · RPTECH ISIN · INE0J1F01024 LEI · 33580098A6ZHLVHU5776 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 229 across all filing types
Latest filing 2024-10-30 Regulatory Filings
Country IN India
Listing BSE.NS RPTECH

About Rashi Peripherals Limited

https://www.rptechindia.com/

Rashi Peripherals Limited operates as a value-added distributor of Information and Communications Technology (ICT) products. The company bridges the gap between global technology brands and a diverse network of channel partners, including retailers, system integrators, and corporate resellers. Its product portfolio includes personal computing devices, mobility solutions, enterprise hardware, computer components, and lifestyle technology. The company maintains strategic partnerships with global original equipment manufacturers such as ASUS, HP, Lenovo, Logitech, NVIDIA, Intel, and Western Digital. Key operational strengths include an extensive logistics network, specialized technical support, and integrated marketing services aimed at enhancing brand presence and market reach. The organization focuses on delivering end-to-end supply chain solutions and technical expertise to support the deployment of advanced technology across various commercial and consumer sectors.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2024-10-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of an analysts/investors meeting held on October 29, 2024. It references Regulation 30(6) of SEBI Listing Obligations and Disclosure Requirements, which pertains to disclosure of material events. The document states that the audio recording of the call has been uploaded on the company's website and provides a link to the recording. The document itself does not contain the transcript or detailed content of the call, only an announcement of the availability of the recording. Given the short length (1689 characters) and the nature of the content as an announcement rather than the full transcript, this fits best under Regulatory Filings (RNS) as a general regulatory announcement. It is not a full Call Transcript (CT) because the transcript is not included, nor is it an Earnings Release or Investor Presentation. It is also not a Report Publication Announcement (RPA) because it is not announcing a report but an audio recording. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-10-29 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated October 29, 2024, reporting the financial results for the quarter ended September 30, 2024. It includes key consolidated financial figures such as total income, EBITDA, and net profit for Q2 FY25 compared to Q2 FY24, along with operational updates and management commentary. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material events including quarterly results. The content is a detailed announcement of quarterly financial performance, not a full interim report with comprehensive financial statements or management discussion and analysis. Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only.
2024-10-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a detailed presentation addressed to stock exchanges and investors, referencing a corporate presentation for an investor/analyst conference call. It includes extensive company overview, business segments, growth drivers, and market positioning information. The document is dated October 29, 2024, and references Q2 & H1 FY25, indicating it is related to quarterly/half-year financial performance. The content is typical of an investor presentation, focusing on strategy, market opportunity, and company highlights rather than a formal financial report or regulatory filing. It is not a transcript of a call, nor an announcement of voting results or capital changes. The document is too long and detailed to be a simple announcement or regulatory filing. Therefore, the most appropriate classification is Investor Presentation (IP).
2024-10-29 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is titled as a "Report of the Monitoring Agency with respect to utilization of proceeds of the Initial Public Offer" for the quarter ended September 30, 2024. It is prepared by CARE Ratings Limited, the Monitoring Agency appointed by the company, and is submitted pursuant to SEBI regulations related to IPO proceeds monitoring. The content includes detailed financial data on the utilization of IPO proceeds, deviations, deployment of unutilized funds, and certifications from Chartered Accountants. The document is a formal report on the use of capital raised through an IPO, focusing on compliance and financial monitoring rather than a general financial performance report or earnings release. It is not an announcement or a brief notice but a substantive report with financial details and analysis related to capital utilization. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes, including monitoring of IPO proceeds utilization.
2024-10-29 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding compliance with SEBI Listing Regulations, specifically Regulation 32(1). It states there are no deviations or variations in the utilization of IPO proceeds for the quarter ended September 30, 2024, and includes a NIL statement of deviation or variation. This type of filing is a regulatory compliance disclosure related to the use of IPO proceeds and quarterly reporting obligations under listing regulations. It is not a full financial report, earnings release, or management discussion. It is also not an announcement of voting results, board changes, or capital changes. The document is short (1870 characters) and serves as a regulatory compliance statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2024-10-29 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.